3George A,Kaysen. The Microinflammatory State in Uremia: Causes and Potential Consequenees[J]. J Am Soe Nephrol, 2001,12: 1549-1557.
4Panichi V,Migliorz M,De Pietro S,etal. C-reactive protein as a marker of ehronie inflammation in uremic patients[J]. Blood Purif,2000,18(3) :183-190.
5Stenvinkel P, Wanner C, Metzger T, et al. Inflammation and outcome in end-stage renal failure:does female gender constitute a survival advantage[J]. Kidney Int, 2002,62 (5) : 1791- 1798.
6Ortega O,Rodriguez I,Gallar P,et al. Significance of high C reactive protein levels in pre-dialysis patients[J]. Nephrol Dial Transplant,2002,17(6) :1105-1109.
7Boenisch O,Ehmke KD, Heddergott A, et al. C-reactive-protein and eytokine plasma levels in hemodialysis patients[J]. Am Soe Nephrol, 2002,15: 547-551.
8Kaysen GA. The microinflammatory state in uremia: causes and potential consequences[J]. J Am Soc Nephrol, 2001,12 (7) :1549-1557.
9Clark WR, Gao D. Low-molecular weight proteins in endstage renal disease: potential toxicity and dialytic removal meehanisms[J]. J Am Soc Nephrol,2002,13(1):41-47.
10Latscha BD, Sarsat VW. Importance of oxidatively modified proteins in chronic renal failure[J]. Kidney Int, 2002, 59 (78) :108-113.
